Smart messages and alerts for an infusion delivery and management system

• US 20070213657A1
• Filed: 02/28/2006
• Published: 09/13/2007
• Est. Priority Date: 02/28/2006
• Status: Active Grant

• Current Assignee: Abbott Diabetes Care Incorporated (Abbott Laboratories Incorporated)
• Original Assignee: Abbott Diabetes Care Incorporated (Abbott Laboratories Incorporated)
• Inventors: Jennewine, R., Krapek, Kimberley
• Granted Patent: US 7,981,034 B2
• Time in Patent Office: Days
• US Class Current: 604/66
• CPC Class Codes: A61B 5/0031 Implanted circuitry
• CPC Class Codes: A61B 5/14532 for measuring glucose, e.g. by tissue impedance measurement
• CPC Class Codes: A61B 5/4839 combined with drug delivery
• CPC Class Codes: G16H 20/17 delivered via infusion or injection
• CPC Class Codes: G16H 40/67 for remote operation
• CPC Class Codes: G16H 50/30 for calculating health indices; for individual health risk assessment

Abstract

Method and system for providing diabetes management is provided.

Claims

1. A method of diabetes management, comprising:

comparing each of a predetermined number of consecutive analyte related levels for a predefined time period to a predetermined target level; and

generating an alert when each of the predetermined number of consecutive analyte related levels deviates from the predetermined target level.

2. The method of claim 1 further including the step of measuring an analyte level of a patient to determine the one or more of the predetermined number of consecutive analyte related levels.

3. The method of claim 2 wherein the measuring step includes the step of using one or more of a discrete blood glucose meter or a continuous analyte monitoring system.

4. The method of claim 1 further including the step of outputting the alert on an infusion device.

5. The method of claim 1 wherein the predefined time period includes one of a time period between 30 minutes and four hours.

6. The method of claim 1 wherein the predetermined number of consecutive analyte related levels include one of two, three, four or five analyte related levels.

7. The method of claim 1 wherein the predetermined target level includes a target high analyte level.

8. The method of claim 1 wherein the analyte levels include glucose levels, and further, wherein the predetermined target level includes a target high glucose level.

9. The method of claim 1 wherein the alert includes one or more of an audible alert, a visual alert, or a tactile alert.

10. The method of claim 9 wherein the visual alert includes one or more of an alphanumeric output display, a graphical output display, an icon display, a video output display, a color display or an illumination display.

11. The method of claim 1 further including the step of outputting the generated alert.

12. The method of claim 1 wherein the predefined time period includes a pre-sleep time period.

13. The method of claim 12 wherein the pre-sleep time period begins at approximately a predetermined number of hours post the last meal of the day, and terminates at the beginning of entering sleep cycle.

14. The method of claim 12 wherein the pre-sleep time period beings at approximately 9 pm and ends at approximately at 12 am in a 24 hour daily time period.

15. The method of claim 1 wherein the predetermined target level includes a target low analyte level.

16. The method of claim 15 wherein the alert is generated when each of the predetermined number of analyte related levels falls below the target low analyte level.

17. A system for providing diabetes management, comprising:

an interface unit configured to receive one or more analyte related data; and

a processor unit operatively coupled to the interface unit, the processor unit configured to perform data processing based on the one or more received analyte related data, the processing unit further configured to generate one or more of an alert or a notification for output via the interface unit;

wherein the processor unit is configured to compare the one or more analyte related data to one or more of a predetermined target analyte levels, and in accordance therewith, generate the one or more of the alert or the notification for one or more of an audible output, visual output or a tactile output.

18. The system of claim 17 wherein the interface unit includes an input unit and an output unit, the input unit configured to receive the one or more analyte related data, and the output unit configured to output the one or more of the alert of the notification.

19. The system of claim 17 wherein the processor unit is configured to receive substantially in real time, a plurality of analyte levels of a patient.

20. The system of claim 17 wherein the interface unit and the processor unit are operatively coupled to a housing of an infusion device.

21. The system of claim 20 wherein the infusion device includes an external insulin pump.

22. A system for providing diabetes management, comprising:

an analyte monitoring system configured to monitor an analyte level of a patient substantially in real time;

a medication delivery unit operatively for wirelessly receiving data associated with the monitored analyte level of the patient substantially in real time from the analyte monitoring system; and

a data processing unit operatively coupled to the one or more of the analyte monitoring system or the medication delivery unit, the data processing unit configured to perform data processing based on the monitored analyte level of the patient, and to generate and output one or more of an alert or notification corresponding to the monitored analyte levels.

23. The system of claim 22 wherein the analyte monitoring system is configured to wirelessly communicate with the medication delivery unit over a radio frequency (RF) communication link, a Bluetooth communication link, an Infrared communication link, or a local area network (LAN).